A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
NCT ID: NCT01262170
Last Updated: 2015-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
109 participants
INTERVENTIONAL
2010-04-30
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
NCT01428310
A Study in a Human Laboratory Model of Smoking Behavior
NCT02641028
The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers
NCT00633256
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
NCT01466361
A Second Study of Cytisinicline for Smoking Cessation in Adult Smokers
NCT05206370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CigRx Lozenge
CigRx Lozenge
CigRx Lozenge
lozenge made of dietary supplements
Tobacco Lozenge
Tobacco Lozenge
Tobacco Lozenge
lozenge made of compressed cured tobacco extract
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CigRx Lozenge
lozenge made of dietary supplements
Tobacco Lozenge
lozenge made of compressed cured tobacco extract
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smoking for at least 5 years
* Smoking at least one (1) pack of cigarettes a day
Exclusion Criteria
23 Years
72 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rock Creek Pharmaceuticals, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria Varga, MD
Role: PRINCIPAL_INVESTIGATOR
Star Scientific, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Comfort Inn
Martinsburg, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RCP-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.